Toxoplasma gondii dissemination: A parasite's journey through the infected host

Parasite Immunology

Volumn 37, Issue 3, 2015, Pages 141-149

  Harker, K S ^a   Ueno, N ^a   Lodoen, M B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Toxoplasma gondii; Adhesion molecules; Gliding motility; Migration; Parasite; Pathogenesis

Indexed keywords

GLYCOSAMINOGLYCAN;

BLOOD; CELL ADHESION; HOST; HOST CELL; HUMAN; INTESTINE MUCOSA; LYMPH VESSEL; NONHUMAN; PARASITE ADHESION; PARASITE MIGRATION; PARASITE MOTILITY; PARASITE PHENOMENA AND FUNCTIONS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VIDEO MICROSCOPY; ADHESION; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; EYE; FEMALE; INTESTINE; LYMPHATIC SYSTEM; MEAT; MOVEMENT (PHYSIOLOGY); PARASITOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; TOXOPLASMA; TRANSMISSION;

ANIMALIA; TOXOPLASMA GONDII;

ADHESIVENESS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; EYE; FEMALE; HUMANS; INTESTINAL MUCOSA; INTESTINES; LYMPHATIC SYSTEM; MEAT; MOVEMENT; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84922984503     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12163     Document Type: Review

References (105)

1. Jones JL & Dubey JP. Foodborne toxoplasmosis. Clin Infect Dis 2012; 55: 845-851.
2. Dubey JP, Lindsay DS & Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 1998; 11: 267-299.
3. Dubey JP, Miller NL & Frenkel JK. The Toxoplasma gondii oocyst from cat feces. J Exp Med 1970; 132: 636-662.
4. Dubey JP. Tissue cyst tropism in Toxoplasma gondii: a comparison of tissue cyst formation in organs of cats, and rodents fed oocysts. Parasitology 1997; 115: 15-20.
5. Derouin F & Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008; 14: 1089-1101.
6. Lindsay DS & Dubey JP. Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis. Parasitology 2011; 138: 1-3.
7. Morisaki JH, Heuser JE & Sibley LD. Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J Cell Sci 1995; 108: 2457-2464.
8. Mordue DG, Hakansson S, Niesman I & Sibley LD. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp Parasitol 1999; 92: 87-99.
9. Goldman M, Carver RK & Sulzer AJ. Reproduction of Toxoplasma gondii by internal budding. J Parasitol 1958; 44: 161-171.
10. Suzuki Y, Orellana MA, Schreiber RD & Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988; 240: 516-518.
11. Lyons RE, McLeod R & Roberts CW. Toxoplasma gondii tachyzoite-bradyzoite interconversion. Trends Parasitol 2002; 18: 198-201.
12. Su C, Khan A, Zhou P, et al. Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc Natl Acad Sci U S A 2012; 109: 5844-5849.
13. Sibley LD & Ajioka JW. Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu Rev Microbiol 2008; 62: 329-351.
14. Khan A, Dubey JP, Su C, et al. Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Int J Parasitol 2011; 41: 645-655.
15. Howe DK & Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 1995; 172: 1561-1566.
16. Boothroyd JC & Grigg ME. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Microbiol 2002; 5: 438-442.
17. Barragan A & Sibley LD. Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J Exp Med 2002; 195: 1625-1633.
18. Saeij JP, Boyle JP, Grigg ME, Arrizabalaga G & Boothroyd JC. Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect Immun 2005; 73: 695-702.
19. Taylor S, Barragan A, Su C, et al. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 2006; 314: 1776-1780.
20. Montoya JG & Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-1976.
21. Suzuki Y, Yang Q, Yang S, et al. IL-4 is protective against development of toxoplasmic encephalitis. J Immunol 1996; 157: 2564-2569.
22. Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009; 49: 878-884.
23. Dupont CD, Christian DA & Hunter CA. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol 2012; 34: 793-813.
24. Porter SB & Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1643-1648.
25. Montoya JG & Remington JS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 1996; 23: 277-282.
26. Randall LM & Hunter CA. Parasite dissemination and the pathogenesis of toxoplasmosis. Eur J Microbiol Immunol (Bp) 2011; 1: 3-9.
27. Dobrowolski JM & Sibley LD. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 1996; 84: 933-939.
28. Keeley A & Soldati D. The glideosome: a molecular machine powering motility and host-cell invasion by Apicomplexa. Trends Cell Biol 2004; 14: 528-532.
29. Achbarou A, Mercereau-Puijalon O, Autheman JM, et al. Characterization of microneme proteins of Toxoplasma gondii. Mol Biochem Parasitol 1991; 47: 223-233.
30. Harper JM, Hoff EF & Carruthers VB. Multimerization of the Toxoplasma gondii MIC2 integrin-like A-domain is required for binding to heparin and human cells. Mol Biochem Parasitol 2004; 134: 201-212.
31. Carruthers VB, Giddings OK & Sibley LD. Secretion of micronemal proteins is associated with toxoplasma invasion of host cells. Cell Microbiol 1999; 1: 225-235.
32. Carruthers VB & Tomley FM. Microneme proteins in apicomplexans. Subcell Biochem 2008; 47: 33-45.
33. Sibley LD. How apicomplexan parasites move in and out of cells. Curr Opin Biotechnol 2010; 21: 592-598.
34. Huynh MH & Carruthers VB. Toxoplasma MIC2 is a major determinant of invasion and virulence. PLoS Pathog 2006; 2: e84.
35. Soldati D, Dubremetz JF & Lebrun M. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int J Parasitol 2001; 31: 1293-1302.
36. Friedrich N, Santos JM, Liu Y, et al. Members of a novel protein family containing microneme adhesive repeat domains act as sialic acid-binding lectins during host cell invasion by apicomplexan parasites. J Biol Chem 2010; 285: 2064-2076.
37. Garcia-Reguet N, Lebrun M, Fourmaux MN, et al. The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite. Cell Microbiol 2000; 2: 353-364.
38. Cerede O, Dubremetz JF, Soete M, et al. Synergistic role of micronemal proteins in Toxoplasma gondii virulence. J Exp Med 2005; 201: 453-463.
39. Dzierszinski F, Mortuaire M, Cesbron-Delauw MF & Tomavo S. Targeted disruption of the glycosylphosphatidylinositol-anchored surface antigen SAG3 gene in Toxoplasma gondii decreases host cell adhesion and drastically reduces virulence in mice. Mol Microbiol 2000; 37: 574-582.
40. Hakansson S, Morisaki H, Heuser J & Sibley LD. Time-lapse video microscopy of gliding motility in Toxoplasma gondii reveals a novel, biphasic mechanism of cell locomotion. Mol Biol Cell 1999; 10: 3539-3547.
41. Leung JM, Rould MA, Konradt C, Hunter CA & Ward GE. Disruption of TgPHIL1 alters specific parameters of Toxoplasma gondii motility measured in a quantitative, three-dimensional live motility assay. PLoS ONE 2014; 9: e85763.
42. Carruthers VB, Hakansson S, Giddings OK & Sibley LD. Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect Immun 2000; 68: 4005-4011.
43. Remington JS & Cavanaugh EN. Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain. N Engl J Med 1965; 273: 1308-1310.
44. Dubey JP, Speer CA, Shen SK, Kwok OC & Blixt JA. Oocyst-induced murine toxoplasmosis: life cycle, pathogenicity, and stage conversion in mice fed Toxoplasma gondii oocysts. J Parasitol 1997; 83: 870-882.
45. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8: 411-420.
46. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9: 799-809.
47. Courret N, Darche S, Sonigo P, et al. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 2006; 107: 309-316.
48. Coombes JL, Charsar BA, Han SJ, et al. Motile invaded neutrophils in the small intestine of Toxoplasma gondii-infected mice reveal a potential mechanism for parasite spread. Proc Natl Acad Sci U S A 2013; 110: E1913-E1922.
49. Gregg B, Taylor BC, John B, et al. Replication and distribution of Toxoplasma gondii in the small intestine after oral infection with tissue cysts. Infect Immun 2013; 81: 1635-1643.
50. Barragan A, Brossier F & Sibley LD. Transepithelial migration of Toxoplasma gondii involves an interaction of intercellular adhesion molecule 1 (ICAM-1) with the parasite adhesin MIC2. Cell Microbiol 2005; 7: 561-568.
51. Weight CM & Carding SR. The protozoan pathogen Toxoplasma gondii targets the paracellular pathway to invade the intestinal epithelium. Ann N Y Acad Sci 2012; 1258: 135-142.
52. Dalton JE, Cruickshank SM, Egan CE, et al. Intraepithelial gammadelta+ lymphocytes maintain the integrity of intestinal epithelial tight junctions in response to infection. Gastroenterology 2006; 131: 818-829.
53. Brossier F & David Sibley L. Toxoplasma gondii: microneme protein MIC2. Int J Biochem Cell Biol 2005; 37: 2266-2272.
54. Sultan AA, Thathy V, Frevert U, et al. TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell 1997; 90: 511-522.
55. Harker KS, Jivan E, McWhorter FY, Liu WF & Lodoen MB. Shear forces enhance Toxoplasma gondii tachyzoite motility on vascular endothelium. MBio 2014; 5: e01111-e01113.
56. McLeod R, Eisenhauer P, Mack D, et al. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J Immunol 1989; 142: 3247-3255.
57. Liesenfeld O, Kosek J, Remington JS & Suzuki Y. Association of CD4 + T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 1996; 184: 597-607.
58. Cohen SB & Denkers EY. Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii. Mucosal Immunol 2014; 7: 744-752.
59. Abernethy TJ. Acquired toxoplasmosis-selected aspects of diagnosis. Trans Am Clin Climatol Assoc 1973; 84: 49-59.
60. Zenner L, Darcy F, Capron A & Cesbron-Delauw MF. Toxoplasma gondii: kinetics of the dissemination in the host tissues during the acute phase of infection of mice and rats. Exp Parasitol 1998; 90: 86-94.
61. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli AE & Denkers EY. Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J Immunol 2008; 181: 8485-8491.
62. Lambert H, Vutova PP, Adams WC, Lore K & Barragan A. The Toxoplasma gondii-shuttling function of dendritic cells is linked to the parasite genotype. Infect Immun 2009; 77: 1679-1688.
63. Fuks JM, Arrighi RB, Weidner JM, et al. GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Pathog 2012; 8: e1003051.
64. Weidner JM, Kanatani S, Hernandez-Castaneda MA, et al. Rapid cytoskeleton remodelling in dendritic cells following invasion by Toxoplasma gondii coincides with the onset of a hypermigratory phenotype. Cell Microbiol 2013; 15: 1735-1752.
65. Persat F, Mercier C, Ficheux D, et al. A synthetic peptide derived from the parasite Toxoplasma gondii triggers human dendritic cells' migration. J Leukoc Biol 2012; 92: 1241-1250.
66. Da Gama LM, Ribeiro-Gomes FL, Guimaraes U Jr & Arnholdt AC. Reduction in adhesiveness to extracellular matrix components, modulation of adhesion molecules and in vivo migration of murine macrophages infected with Toxoplasma gondii. Microbes Infect 2004; 6: 1287-1296.
67. Persson CM, Lambert H, Vutova PP, et al. Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infect Immun 2009; 77: 970-976.
68. Chtanova T, Han SJ, Schaeffer M, et al. Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node. Immunity 2009; 31: 342-355.
69. Lambert H, Hitziger N, Dellacasa I, Svensson M & Barragan A. Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol 2006; 8: 1611-1623.
70. Unno A, Suzuki K, Xuan X, et al. Dissemination of extracellular and intracellular Toxoplasma gondii tachyzoites in the blood flow. Parasitol Int 2008; 57: 515-518.
71. Silveira C, Vallochi AL, Rodrigues da Silva U, et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol 2011; 95: 396-400.
72. Channon JY, Seguin RM & Kasper LH. Differential infectivity and division of Toxoplasma gondii in human peripheral blood leukocytes. Infect Immun 2000; 68: 4822-4826.
73. Gordon S & Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
74. Varol C, Yona S & Jung S. Origins and tissue-context-dependent fates of blood monocytes. Immunol Cell Biol 2009; 87: 30-38.
75. Popel AS & Johnson PC. Microcirculation and Hemorheology. Annu Rev Fluid Mech 2005; 37: 43-69.
76. Johnston B & Butcher EC. Chemokines in rapid leukocyte adhesion triggering and migration. Semin Immunol 2002; 14: 83-92.
77. Ley K, Laudanna C, Cybulsky MI & Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7: 678-689.
78. Abram CL & Lowell CA. The ins and outs of leukocyte integrin signaling. Annu Rev Immunol 2009; 27: 339-362.
79. Alon R & Dustin ML. Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and antigen-presenting cells. Immunity 2007; 26: 17-27.
80. Harker KS, Ueno N, Wang T, et al. Toxoplasma gondii modulates the dynamics of human monocyte adhesion to vascular endothelium under fluidic shear stress. J Leukoc Biol 2013; 93: 789-800.
81. Ueno N, Harker KS, Clarke EV, et al. Real-time imaging of Toxoplasma-infected human monocytes under fluidic shear stress reveals rapid translocation of intracellular parasites across endothelial barriers. Cell Microbiol 2014; 16: 580-595.
82. Luft BJ & Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15: 211-222.
83. Berenreiterova M, Flegr J, Kubena AA & Nemec P. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS ONE 2011; 6: e28925.
84. Dellacasa-Lindberg I, Hitziger N & Barragan A. Localized recrudescence of Toxoplasma infections in the central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging. Microbes Infect 2007; 9: 1291-1298.
85. Abbott NJ, Ronnback L & Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41-53.
86. Lachenmaier SM, Deli MA, Meissner M & Liesenfeld O. Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J Neuroimmunol 2011; 232: 119-130.
87. Dellacasa-Lindberg I, Fuks JM, Arrighi RB, et al. Migratory activation of primary cortical microglia upon infection with Toxoplasma gondii. Infect Immun 2011; 79: 3046-3052.
88. Lambert H, Dellacasa-Lindberg I & Barragan A. Migratory responses of leukocytes infected with Toxoplasma gondii. Microbes Infect 2011; 13: 96-102.
89. Butler NJ, Furtado JM, Winthrop KL & Smith JR. Ocular toxoplasmosis II: clinical features, pathology and management. Clin Experiment Ophthalmol 2013; 41: 95-108.
90. Ajzenberg D, Cogne N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002; 186: 684-689.
91. Olariu TR, Remington JS, McLeod R, Alam A & Montoya JG. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J 2011; 30: 1056-1061.
92. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996; 114: 593-599.
93. Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology 2009; 116: 1544-1551, 1551 e1541.
94. Klaassen I, Van Noorden CJ & Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 2013; 34: 19-48.
95. Furtado JM, Ashander LM, Mohs K, et al. Toxoplasma gondii migration within and infection of human retina. PLoS ONE 2013; 8: e54358.
96. Furtado JM, Bharadwaj AS, Ashander LM, Olivas A & Smith JR. Migration of Toxoplasma gondii-infected dendritic cells across human retinal vascular endothelium. Invest Ophthalmol Vis Sci 2012; 53: 6856-6862.
97. Furtado JM, Bharadwaj AS, Chipps TJ, et al. Toxoplasma gondii tachyzoites cross retinal endothelium assisted by intercellular adhesion molecule-1 in vitro. Immunol Cell Biol 2012; 90: 912-915.
98. Robbins JR & Bakardjiev AI. Pathogens and the placental fortress. Curr Opin Microbiol 2012; 15: 36-43.
99. Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829-1833.
100. Abbasi M, Kowalewska-Grochowska K, Bahar MA, et al. Infection of placental trophoblasts by Toxoplasma gondii. J Infect Dis 2003; 188: 608-616.
101. Pfaff AW, Abou-Bacar A, Letscher-Bru V, et al. Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-gamma. Parasitology 2007; 134: 1895-1902.
102. Ferro EA, Mineo JR, Ietta F, et al. Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants. Am J Pathol 2008; 172: 50-58.
103. de Oliveira Gomes A, de Oliveira Silva DA, Silva NM, et al. Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age. Am J Pathol 2011; 178: 2792-2801.
104. Robbins JR, Zeldovich VB, Poukchanski A, Boothroyd JC & Bakardjiev AI. Tissue barriers of the human placenta to infection with Toxoplasma gondii. Infect Immun 2012; 80: 418-428.
105. Collantes-Fernandez E, Arrighi RB, Alvarez-Garcia G, et al. Infected dendritic cells facilitate systemic dissemination and transplacental passage of the obligate intracellular parasite Neospora caninum in mice. PLoS ONE 2012; 7: e32123.